4//SEC Filing
667, L.P. 4
Accession 0001144204-15-005419
CIK 0001576263other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:33 PM ET
Size
18.7 KB
Accession
0001144204-15-005419
Insider Transaction Report
Form 4
BAKER BROS. ADVISORS LP
10% Owner
Transactions
- Purchase
Common Stock
2015-01-29$20.00/sh+34,065$681,300→ 159,934 total(indirect: See Footnote) - Purchase
Common Stock
2015-01-29$20.00/sh+390,935$7,818,700→ 2,604,832 total(indirect: See Footnote)
Holdings
- 40,308(indirect: See Footnote)
Common Stock
BAKER JULIAN
10% Owner
Transactions
- Purchase
Common Stock
2015-01-29$20.00/sh+34,065$681,300→ 159,934 total(indirect: See Footnote) - Purchase
Common Stock
2015-01-29$20.00/sh+390,935$7,818,700→ 2,604,832 total(indirect: See Footnote)
Holdings
- 40,308(indirect: See Footnote)
Common Stock
Baker Bros. Advisors (GP) LLC
10% Owner
Transactions
- Purchase
Common Stock
2015-01-29$20.00/sh+390,935$7,818,700→ 2,604,832 total(indirect: See Footnote) - Purchase
Common Stock
2015-01-29$20.00/sh+34,065$681,300→ 159,934 total(indirect: See Footnote)
Holdings
- 40,308(indirect: See Footnote)
Common Stock
Baker Brothers Life Sciences LP
10% Owner
Transactions
- Purchase
Common Stock
2015-01-29$20.00/sh+34,065$681,300→ 159,934 total(indirect: See Footnote) - Purchase
Common Stock
2015-01-29$20.00/sh+390,935$7,818,700→ 2,604,832 total(indirect: See Footnote)
Holdings
- 40,308(indirect: See Footnote)
Common Stock
667, L.P.
10% Owner
Transactions
- Purchase
Common Stock
2015-01-29$20.00/sh+34,065$681,300→ 159,934 total(indirect: See Footnote) - Purchase
Common Stock
2015-01-29$20.00/sh+390,935$7,818,700→ 2,604,832 total(indirect: See Footnote)
Holdings
- 40,308(indirect: See Footnote)
Common Stock
BAKER FELIX
10% Owner
Transactions
- Purchase
Common Stock
2015-01-29$20.00/sh+34,065$681,300→ 159,934 total(indirect: See Footnote) - Purchase
Common Stock
2015-01-29$20.00/sh+390,935$7,818,700→ 2,604,832 total(indirect: See Footnote)
Holdings
- 40,308(indirect: See Footnote)
Common Stock
Footnotes (5)
- [F1]As a result of their ownership interest in 14159 Capital(GP), LLC, Julian C. Baker and Felix J. Baker may be deemed to have an indirect pecuniary interest in 40,308 shares of Common Stock of the Issuer directly held by 14159, L.P. ("14159"), a limited partnership of which the sole general partner is 14159 Capital, L.P., a limited partnership of which the sole general partner is 14159 Capital (GP), LLC, due to 14159 Capital, L.P.'s right to receive an allocation of a portion of the profits from 14159.
- [F2]On January 29, 2015 667, L.P.("667") and Baker Brothers Life Sciences, L.P. ("Life Sciences"together with 667, the "Funds") purchased 34,065 and 390,935 shares of the Issuer's Common Stock, respectively, pursuant to an underwritten public offering.
- [F3]After giving effect to the transaction reported herein, and as a result of their ownership interest in Baker Biotech Capital (GP), LLC, Julian C. Baker and Felix J. Baker may be deemed to have an indirect pecuniary interest in the Issuer's shares of Common Stock reported in column 5 of Table I directly held by 667, a limited partnership of which the sole general partner is Baker Biotech Capital, L.P., a limited partnership of which the sole general partner is Baker Biotech Capital (GP), LLC, due to Baker Biotech Capital, L.P.'s right to receive an allocation of a portion of the profits from 667.
- [F4]After giving effect to the transaction reported herein, and as a result of their ownership interest in Baker Brothers Life Sciences Capital (GP), LLC, Julian C. Baker and Felix J. Baker may be deemed to have an indirect pecuniary interest in the Issuer's shares of Common Stock reported in column 5 of Table I directly held by Life Sciences, a limited partnership of which the sole general partner is Baker Brothers Life Sciences Capital, L.P., a limited partnership of which the sole general partner is Baker Brothers Life Sciences Capital (GP), LLC, due to Baker Brothers Life Sciences Capital, L.P.'s right to receive an allocation of a portion of the profits from Life Sciences.
- [F5]Baker Bros. Advisors LP (the "Adviser") serves as the Investment Adviser to the Funds. In connection with the services provided by the Adviser, the Adviser receives an asset-based management fee that does not confer any pecuniary interest in the securities held by the Funds. Baker Bros. Advisors (GP) LLC (the "Adviser GP") is the Adviser's sole general partner. Julian C. Baker and Felix J. Baker are principals of the Adviser GP. The Adviser has complete and unlimited discretion and authority with respect to the investment and voting power of the securities held by the Funds. The general partners of the Funds relinquished to the Adviser all discretion and authority with respect to the investment and voting power of the securities held by the Funds. Julian C. Baker, Felix J. Baker, the Adviser GP and the Adviser disclaim beneficial ownership of the securities held directly by the Funds except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that any of Julian C. Baker, Felix J. Baker, the Adviser GP or the Adviser is a beneficial owner of such securities for purposes of Section 16 or any other purpose.
Documents
Issuer
Mirati Therapeutics, Inc.
CIK 0001576263
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001551139
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 5:33 PM ET
- Size
- 18.7 KB